Research Roundup


Debbie Rigby rounds up the latest in research news Assessment of adverse effects attributed to statin therapy in product labels Findings from a meta-analysis of individual participant-level data from double-blind randomized controlled trials do not provide evidence for causal associations between statin therapy and the majority of conditions listed on product labels as potential adverse

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘Increasingly adversarial’ debate around pharmacist prescribing
Next Race for Infinity down to four